Analyzing Glucose Health (GLUC) and Its Competitors

Glucose Health (OTCMKTS:GLUC) is one of 53 public companies in the “Medicinals & botanicals” industry, but how does it compare to its peers? We will compare Glucose Health to similar companies based on the strength of its analyst recommendations, profitability, dividends, risk, valuation, institutional ownership and earnings.

Analyst Ratings

This is a breakdown of current recommendations for Glucose Health and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glucose Health	0	0	0	0	N/A
Glucose Health Competitors	272	555	993	74	2.46

As a group, “Medicinals & botanicals” companies have a potential upside of 48.67%. Given Glucose Health’s peers higher probable upside, analysts clearly believe Glucose Health has less favorable growth aspects than its peers.

Volatility & Risk

Glucose Health has a beta of 3.51, meaning that its stock price is 251% more volatile than the S&P 500. Comparatively, Glucose Health’s peers have a beta of 1.20, meaning that their average stock price is 20% more volatile than the S&P 500.

Insider & Institutional Ownership

15.8% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 21.3% of shares of all “Medicinals & botanicals” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Glucose Health and its peers gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Glucose Health	$540,000.00	-$420,000.00	-6.29
Glucose Health Competitors	$323.80 million	-$49.81 million	-16.11

Glucose Health’s peers have higher revenue, but lower earnings than Glucose Health. Glucose Health is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Glucose Health and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Glucose Health	-75.00%	N/A	N/A
Glucose Health Competitors	-41.35%	-262.15%	-7.81%

About Glucose Health

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.